Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Ragwitek in Ragweed Allergic Adults
NCT01469182Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Nov 2011
- Primary completion
- Apr 2012
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of SQ SLIT-tablet in ragweed allergy, allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Nov 2011; status: completed.
02
Drugs
SQ SLIT-tablet
03
Conditions
ragweed allergyallergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT01469182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469182.